Olivier Delattre, MD, PhD

Institut Curie
Paris, Ile-de-France, France

Disclosure information not submitted.

Presentation(s):

• Paper 47 - TARGETING DEDIFFERENTIATED LIPOSARCOMA CELL OF ORIGIN WITH TGF-BETA INHIBITION

  Friday, November 15, 2024
  9:00 AM – 10:00 AM PST

• Paper 61 - CROSS-SPECIES COMPARATIVE ONCOLOGY APPROACHES FOR MODELING FUSION-DRIVEN INFANTILE RHABDOMYOSARCOMA

  Friday, November 15, 2024
  2:00 PM – 3:00 PM PST